Dan Brennan
Stock Analyst at UBS
(4.05)
# 396
Out of 4,814 analysts
105
Total ratings
48.81%
Success rate
11.34%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $1.78 | +40.85% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $40.45 | +82.94% | 2 | Feb 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $75 → $118 | $95.50 | +23.56% | 3 | Jan 7, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $41.59 | +106.81% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $148.08 | +18.18% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $105.93 | +136.00% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $37.74 | +85.48% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $71.16 | +148.74% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $95.54 | +50.72% | 3 | Nov 5, 2024 | |
| WAT Waters | Maintains: Hold | $363 → $410 | $321.12 | +27.68% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $190.66 | +65.22% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $102.47 | +56.14% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $45.18 | -7.04% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $7.63 | +293.18% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $15.40 | +101.30% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $436.79 | +50.64% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $44.06 | +15.76% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.56 | +399.64% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $9.54 | +109.64% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $7.51 | +326.10% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $251.08 | +117.46% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.58 | +344.44% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.17 | +1,182.05% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $139.30 | +66.55% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,014.38 | -13.25% | 3 | Oct 7, 2020 |
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $1.78
Upside: +40.85%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $40.45
Upside: +82.94%
GeneDx Holdings
Jan 7, 2025
Maintains: Buy
Price Target: $75 → $118
Current: $95.50
Upside: +23.56%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $41.59
Upside: +106.81%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $148.08
Upside: +18.18%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $105.93
Upside: +136.00%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $37.74
Upside: +85.48%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $71.16
Upside: +148.74%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $95.54
Upside: +50.72%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $321.12
Upside: +27.68%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $190.66
Upside: +65.22%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $102.47
Upside: +56.14%
Aug 8, 2024
Maintains: Buy
Price Target: $41 → $42
Current: $45.18
Upside: -7.04%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $7.63
Upside: +293.18%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $15.40
Upside: +101.30%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $436.79
Upside: +50.64%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $44.06
Upside: +15.76%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.56
Upside: +399.64%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $9.54
Upside: +109.64%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $7.51
Upside: +326.10%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $251.08
Upside: +117.46%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.58
Upside: +344.44%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.17
Upside: +1,182.05%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $139.30
Upside: +66.55%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,014.38
Upside: -13.25%